{"DataElement":{"publicId":"2182234","version":"1.1","preferredName":"Malignant Neoplasm Necrosis Percentage Range","preferredDefinition":"a numeric range indicating an estimated percentage for the extent or magnitude of localized death of living cells associated with presence of tumor composed of atypical neoplastic cells.","longName":"MALNEO_NECR_PTG_RANG","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2182233","version":"2","preferredName":"Malignant Neoplasm Necrosis","preferredDefinition":"information related to the localized death of living cells associated with presence of tumor composed of atypical neoplastic cells.","longName":"MALIG_NEOPL_NECR","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2448417","version":"1","preferredName":"Necrosis","preferredDefinition":"Necrosis; the localized death of living cells as from infection or the interruption of blood supply; unprogrammed death of living tissue.","longName":"C16897","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Necrotic Process","conceptCode":"C16897","definition":"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C236CBF-CD55-2FB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0C236CBF-CD26-2FB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeDescription":"3/22/22 jk added \"Qualified\" RS as part of MCL quarterly content review. ---- updated/revised to provide naming consistency for related elements using EVS terms","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182232","version":"2","preferredName":"Malignant Neoplasm Necrosis Percentage Range","preferredDefinition":"a numeric range indicating an estimated percentage for the extent or magnitude of localized death of living cells associated with presence of tumor composed of atypical neoplastic cells.","longName":"MALNEO_NECR_PTG_RANG","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"> 98%","valueDescription":"> 98%","ValueMeaning":{"publicId":"2568913","version":"1","preferredName":"> 98%","longName":"2568913","preferredDefinition":"> 98%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA3E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C1964DE-9E72-0434-E044-0003BA3F9857","beginDate":"2004-03-30","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","deletedIndicator":"No"},{"value":"<= 98% and > 90%","valueDescription":"<= 98% and > 90%","ValueMeaning":{"publicId":"2568912","version":"1","preferredName":"<= 98% and > 90%","longName":"2568912","preferredDefinition":"<= 98% and > 90%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA3D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C1964DE-9E73-0434-E044-0003BA3F9857","beginDate":"2004-03-30","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","deletedIndicator":"No"},{"value":"<= 90% and > 50%","valueDescription":"<= 90% and > 50%","ValueMeaning":{"publicId":"2568911","version":"1","preferredName":"<= 90% and > 50%","longName":"2568911","preferredDefinition":"<= 90% and > 50%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA3C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C1964DE-9E74-0434-E044-0003BA3F9857","beginDate":"2004-03-30","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","deletedIndicator":"No"},{"value":"<= 50%","valueDescription":"<= 50%","ValueMeaning":{"publicId":"2568910","version":"1","preferredName":"<= 50%","longName":"2568910","preferredDefinition":"<= 50%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA3B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C1964DE-9E75-0434-E044-0003BA3F9857","beginDate":"2004-03-30","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2448434","version":"1","preferredName":"Percentage Range","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:Range; the difference between the lowest and highest numerical values.","longName":"C25613:C38013","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Range","conceptCode":"C38013","definition":"The difference between the lowest and highest numerical values; the limits or scale of variation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C1964DE-9E95-0434-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"ONEDATA","dateModified":"2006-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C1964DE-9E5C-0434-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"WONGW","dateModified":"2014-03-11","changeDescription":"updated for ISO compliance using EVS terms to provide consist naming for related elements","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000027","version":"1","longName":"Bone Sarcoma New","context":"CTEP"},{"publicId":"10000028","version":"1","longName":"Bone Sarcoma Recur","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percent Necrosis","type":"Preferred Question Text","description":"Percent Necrosis","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Percent necrosis (%):","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0C1964DE-9D21-0434-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-06","modifiedBy":"DAVISJ","dateModified":"2016-03-21","changeDescription":"updated/revised to provide naming consistency for related data elements using EVS terms","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}